Conditional amino acid / sulfonate

Plain-language summaryIntrigue 60 / 100

Taurine is a sulfonate amino acid abundant in heart, retina, and brain. Conditional rather than essential (the body makes it from cysteine). Has cardioprotective, anti-inflammatory, and GABAergic effects. Found in energy drinks where the contribution to performance is contested. Not stocked by Kodiac. This monograph is provided for research and educational reference.

Intrigue 0–100 blends mechanism novelty, evidence strength, and translational potential. Kodiac editorial, not peer-reviewed.

Our opinion on this compoundBasic amino acid

32/100

Basic endogenous sulfonate with an interesting 2023 longevity paper but fundamentally mature and low bench priority

Cap applied basic amino acid cap (32)

Yeah, taurine. The Singh et al. 2023 Science paper put this on a lot of radars, and we get why. A multi-species lifespan and healthspan study in a top journal, showing that plasma taurine declines with age and that supplementation partially reverses that decline in mice, worms, and cynomolgus monkeys, thats genuinely interesting. We’re not dismissing it.

But here’s the thing: taurine is still an endogenous sulfonate that’s been in the literature since the 1970s. It’s in energy drinks. Your cat food is fortified with it. The mechanisms, including bile acid conjugation, osmotic regulation, calcium handling in cardiac tissue, and modulation of GABA and glycine receptor activity, are textbook biology at this point. None of that is novel territory, and none of it gives an investigator a new handle on a hard problem.

What the Singh paper actually does is give an old compound a new frame: if circulating taurine is a biomarker of biological aging, and supplementation restores youthful levels, then you have a plausible longevity rationale that wasn’t clearly articulated before. The effect sizes in mice were meaningful, around 10 to 12 percent lifespan extension, and the monkey healthspan marker data is intriguing. But the human arm of that study was observational, not interventional. There is no RCT demonstrating human longevity benefit, and the bench-to-clinic gap for longevity endpoints is one of the hardest translation problems in the field.

The cardiovascular and exercise literature is older and reasonably solid. Taurine has real roles in cardiac calcium handling; there’s clinical evidence for benefits in heart failure patients at gram-level doses. The exercise literature is mixed. None of it is particularly surprising given the known mechanisms.

As a research tool, taurine has limited probe value. If you’re studying GABAergic or glycinergic neurotransmission, there are more selective tools. If you’re studying longevity pathways, MOTS-c, rapamycin, or even GLP-1 class compounds offer more mechanistic traction. Taurine’s bench utility is mostly in confirming effects you already suspect rather than uncovering new biology.

Honestly, if you’re building a research program around the Singh findings, the interesting question isn’t whether taurine supplementation does something, but why taurine declines with age and what upstream process drives that. Taurine itself is probably not the most productive research object. The 2023 paper is a pointer, not a destination, and at Kodiac we’d deprioritize this one relative to compounds with genuinely novel mechanisms or more compelling human interventional evidence.

Novelty: 26
Mechanism promise: 30
In-category differentiation: 20
Evidence quality: 55
Translational signal: 40
Research bench value: 35

Rationale Singh et al. 2023 (Science) gives taurine a genuine new angle with multi-species lifespan data and the plasma-decline-with-age framing, pushing evidence and translational scores above floor; however, the compound is still an endogenous sulfonate with textbook-level mechanisms and no human interventional longevity RCT, so the raw overall clears the basic-aa cap and the cap binds at 32.

Conditional amino acid / sulfonate

An endogenous sulfonate amino acid with osmolyte, calcium-handling, and bile acid conjugation roles, recently associated with longevity in animal models.

Abstract

Taurine (2-aminoethanesulfonic acid; CAS 107-35-7; molecular formula C2H7NO3S; molecular weight 125.15) is an endogenous sulfonate “amino acid” (taurine has a sulfonate group rather than a carboxylate) with widespread tissue distribution and multiple physiological roles: bile acid conjugation, osmotic regulation, calcium handling in cardiac tissue, and modulation of GABA and glycine neurotransmission. Plasma taurine declines with age. A 2023 Science paper (Singh et al.) demonstrated that taurine supplementation extends lifespan and healthspan in mice, monkeys, and worms; the result generated significant interest in taurine as a longevity intervention. Doses for longevity applications are typically 3 to 6 grams per day; doses for cardiovascular and exercise applications are 1 to 6 grams. Excellent safety profile.

Read the full monograph

The full reference document covers compound identification, discovery and developmental history, mechanism of action, pharmacokinetics, sourcing and quality verification, and a curated reference list. Embedded inline below; download for offline reading.

KDC-MN-182Open in new tab →

Download PDF →

FOR RESEARCH USE ONLY. Not for medical, diagnostic, or therapeutic purposes. Not for human consumption. All information is provided for research and educational purposes only.

Tag: Conditional amino acid / sulfonate

Taurine

Abstract

Read the full monograph